Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3711_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
32 Мб
Скачать
194
https://t.me/med1917
Fig. 13.6 Omni-retractor setup, and exposure
when improved exposure of the distal arch and left subcla­vian is required. The eight or ninth space may be utilized to approach an extent III aneurysm with little thoracic compo­nent. Oftentimes, both fth space and an eighth space entry is required for an extent II aneurysm spanning the entire thoracoabdominal aorta.
Once the ribs are reached, the scapular fascial plane just above the ribs is mobilized all the way posteriorly. Staying on the superior aspect of the rib the thoracic cavity is entered and the posterior rib is shingled with a Guillotine. The under­surface of the diaphragm is encountered and dissecting fur­ther leads into the correct retroperitoneal plane. Once the retroperitoneum is free, the endo-GIA blue staple load is uti­lized to staple and transect the diaphragm circumferentially, taking care to avoid injuring the phrenic nerve. Leaving a 2–3cm cuff of diaphragm on the chest wall and marking the staple line on either side with sutures facilitates later re­approximation of the diaphragm. This plane is then worked caudally till the psoas muscle is reached. The peritoneum is continually rolled toward the patient’s right side as this plane is developed thereby executing a medial visceral rotation.
The Omni retractors are set up to provide adequate expo­sure within the abdominal cavity and the Finochietto rib spreaders are placed to provide intercostal exposure (Fig.13.6). Two rib spreaders are used if a higher intercostal space (e.g., fourth interspace) is also entered for exposure. Special care and attention is directed to padded retention of the spleen to avoid capsular tear and injury.
A. Venkataraman and J. P. Schwartz
graft. Alternatively, an additional tube graft (10–12mm) can be used to anastomose the intercostal vessels to the main Dacron graft.
Repair oftheAbdominal Aortic Segment
The infrarenal abdominal aorta is clamped sequentially and opened. The visceral vessels are identied and perfused with cold blood via appropriately sized Pruitt balloon tipped cath­eters [33] (Figs.13.7 and 13.8). The visceral vessels are then anastomosed to the Dacron graft either as an island patch or individually by using short interposition bypass grafts. Individual interposition bypass grafts tend to take longer for the anastomoses to be completed but tend to be easier to visualize and to be more hemostatic subsequently (Fig.13.9).
Fig. 13.7 Pruitt balloon tipped catheters
Repair oftheThoracic Aortic Segment
The thoracic aorta is clamped sequentially and the aorta between clamps opened and a Dacron graft is sutured to the proximal descending thoracic aorta. All lower intercostal arteries from T8 to T12 are reattached either individually or together as a patch to an elliptical incision in the Dacron
Fig. 13.8 Pruitt catheters utilized to perfuse individual mesenteric
vessels
13 Thoracoabdominal Aneurysms
https://t.me/med1917
195
circulatory support. At our institution, we commonly employ femoral–femoral cardiopulmonary bypass as described below.
Femoral–Femoral Cardiopulmonary Bypass
Our preferred approach has been to cannulate the left femo­ral vein with an extended venous cannula that is extended to the level of the right atrium under transesophageal guidance. Arterial cannulation is also performed via the femoral artery and full cardiopulmonary bypass is established.
Fig. 13.9 Individual grafts anastomosed to individual mesenteric ves-
sels and renal vessels
Fig. 13.10 Completely reconstructed thoracoabdominal aorta with
branch side grafts to visceral and renal vessels
If an island patch technique is used, typically the left renal artery is located too far and requires a separate short interpo­sition bypass graft. Once the visceral anastomosis is complete the clamp is moved further down the graft and ow is rees­tablished to the viscera and kidneys (Fig.13.10).
Circulatory Support Options
A variety of strategies have been employed for circulatory support or extracorporeal bypass for TAAA repair. Left heart bypass (LHB) is considered the minimum and the resultant decompression of the proximal circulation in conjunction distal perfusion of the abdominal viscera, spi­nal cord, and lower extremities decreases complications associated with ischemia. Many groups advocate left heart bypass and use this technique as their preferred mode of
Left Heart Bypass
Left atrial drainage is established via the inferior pulmonary vein. Arterial inow is established by cannulation of the iliac system after exposure of the bifurcation, thereby providing adequate retrograde ow to the visceral segment and the spi­nal cord via the internal iliac system and antegrade ow to bilateral lower extremities.
Organ Protection
Neurologic Protection
The risk of postoperative neurologic decits (paraplegia and paraparesis) has always plagued the repair of thoracoab­dominal aneurysm with graft replacement since its incep­tion. The development of a classication system for the extent of an aneurysm had revealed that extent had a direct correlation with neurological outcome in these operations. In the era of simple cross-clamp techniques, immediate sur­vival rates were fairly impressive, but the rate of neurologic events (particularly in extent II aneurysms) remained persis­tently high. These poor neurologic outcomes were clearly related to the aneurysm extent, rupture, clamp time, patient age, and proximal disease. Over the years, several adjuncts have been developed to improve upon these outcomes with good results.
The technique of combined cerebrospinal uid (CSF) drainage and distal aortic perfusion has consistently been shown to provide superior neurological outcomes. The utili­zation of moderate hypothermia, active visceral cooling and selective visceral perfusion, and aggressive intercostal artery reattachments has further augmented the success of these adjuncts [9]. Spinal catheters are inserted routinely by the anesthesiology team in the third of fourth lumbar space. The CSF pressure is kept at 10mmHg or less intraoperatively, and the drain is kept in place usually for 3days postoperatively. Because of the association of arterial blood pressure and oxy-
196
https://t.me/med1917
A. Venkataraman and J. P. Schwartz
gen delivery to delayed neurologic decit, we maintain mean arterial pressure (MAP) between 90mmHg and 100mmHg, hemoglobin above 10 mg/dl, and a cardiac index above
2.0L/min. Urine output is closely monitored. In the event that delayed neurologic decit occurs after removal of the CSF drain, a new CSF drain is placed urgently and drained freely for 2–3days and the CSF pressure kept below 10mmHg.
In current times, the overall rate of neurological events is approximately 3% compared to 15% of patients during the era of cross-clamp without adjuncts [9, 25]. The most notice­able result of adjuncts has been the signicant reduction in neurologic decits in extent II repairs, 6.6% at present com­pared with previous incidence of 31% [25].
Renal andVisceral Protection
Distal aortic ischemia during TAA repair carries a formida­ble risk of perioperative morbidity and mortality. Renal dys­function occurs in as many as 28% of patients undergoing TAAA repairs, and necessitates dialysis in 4–11% of patients [34]. With the advancement of surgical techniques and adjuncts signicant improvements in open TAAA repair have been achieved [35, 36]. The two primary approaches that have emerged to maintain distal aortic perfusion and selective visceral perfusion are that of left heart bypass (LHB) and full cardiopulmonary bypass.
Left heart bypass (LHB) is used as a closed circuit with the addition of a reservoir to salvage shed blood, and can be used to maintain distal perfusion and pressure adjusted accordingly to maintain stable hemodynamics. Visceral perfusion can be provided using either isothermic (37°C) or cold blood (4 °C) or crystalloid of all four branching arteries [37].
Full cardiopulmonary bypass may also be used with a wide range of protective hypothermic strategies such as mild (34°C) to profound (18°C) systemic hypothermia, during the repair. Partial cardiopulmonary bypass with three sepa­rate roller pumps for femoral–femoral bypass, celiac axis and superior mesenteric artery perfusion, and bilateral renal perfusion has also been described [38]. In some studies, cold crystalloid perfusion was noted to protect against renal dys­function over isothermic blood for renal perfusion [39]. In studies comparing either cold blood versus cold crystalloid for renal perfusion, no signicant difference was noted between patients with regard to early death or renal failure [37]. Recent aortic guidelines recommend the use of either cold blood or cold crystalloid renal perfusion; however, the exact techniques and additives vary amongst centers [19].
Concomitant visceral and renal artery occlusive disease is present in a signicant proportion of patients with TAAAs [40]. Techniques such as renal endarterectomy or the use of balloon expandable stents to improve renal and visceral
blood ow have demonstrated benets such as fewer renal failures in patients with preexisting renal dysfunction [26,
40]. The use of visceral stents in treating mesenteric and
renal occlusive disease is a new strategy that is gaining acceptance [41]. The visceral stents prove useful in obliterat­ing the false lumen associated with concomitant aortic dis­sections, keeping the ostia patent near patch anastomoses. Although usually safe and effective, drawbacks include risk of thrombosis, possibility of vessel perforation and stent migration.
In the literature, the incidence of renal dysfunction is highest after extent II TAAA repairs, which correlated with prolonged protected and unprotected renal ischemia times. Bowel ischemia occurred in only 1% of patients; however, it had a substantial consequent attendant mortality of 88% [34]. Thus, contemporary protective strategies enable patients to undergo open TAAA repair with substantially fewer renal and visceral ischemic complications than in pre­vious decades.
Endovascular Repair
Endovascular aneurysm repair (EVAR) therapy offers a potential alternative for patients who are physiologically high risk for conventional surgery. Initially, advanced EVAR was limited to short-necked abdominal aortic aneurysms, but the development of the aortic endograft and bridging stent graft technology has expanded its role to include fur­ther aortic coverage [42]. Early experience with application of fenestrated and branched endografts to treat more exten­sive TAAA demonstrates acceptable outcomes [43]. The rates of perioperative mortality, renal failure, and spinal cord ischemia challenge outcomes attained for conventional surgery in high-volume centers [44]. Renal failure and spi­nal cord ischemia (SCI) remain the most concerning postop­erative morbidity in complex fenestrated branched endovascular repair of TAAA.Renal failure occurred at a rate of 2.8% in some series, with an incidence of 5.5% in the subpopulation that underwent Type II repair [45]. SCI symptoms developed in 8% of patients overall, but resolved in nearly half the patients prior to hospital discharge in the same series [45]. These outcomes are comparable with the results contemporary open repair.
Staging of endovascular repair has been reported to be associated with reduced incidence and severity of SCI. Staging has its own risks. Before custom endografts were available, staging was a necessity. However, a propor­tion of these patients die between stages (6%) and aneurysm rupture is thought to be a causative factor [46]. From a tech­nical standpoint, the need for the use of reinforced fenestra­tions in the endovascular treatment of complex TAAA may be associated with higher rate of visceral and renal endoleaks
13 Thoracoabdominal Aneurysms
https://t.me/med1917
197
and suboptimal patency rates [47]. Endoleaks also increase the risk and need for reinterventions, but this has not appeared to adversely affect longer-term outcomes. Evolving graft and bridging stent design improvement may help to mitigate this in future.
Hybrid Repair
The perioperative morbidity and mortality associated with open surgical repair of TAAA has always remained signi­cant. The complications of acute renal failure (2–12%) and cardiopulmonary (4–33%) and spinal cord ischemia (1–15%) are signicant and are increased when preoperative pulmo­nary and renal impairment is present [48]. Complete endo­vascular exclusion of TAAA, while feasible, remains a technique that is in evolution and has its shortcomings as discussed above. Therefore, a hybrid approach mixing stable endovascular exclusion of TAAAs after open visceral bypass has evolved into a viable treatment option. The general premise of the hybrid approach is based on the reduced phys­iologic stress of operating through one visceral cavity rather than two (abdomen and thorax), thereby reducing complica­tions and improving ultimate outcome.
Visceral hybrid TAAA repair utilizes retrograde revascu­larization of the visceral and renal arteries via an open abdominal approach. This preparatory operation then enables an endovascular stent-graft to exclude the TAAA including the visceral aortic segment. Compared to open techniques, this approach reduces visceral ischemia time. Spinal cord ischemia, attributed to aortic cross-clamping, intraoperative hypotension and reperfusion injury are theoretically mini­mized. The avoidance of a thoracotomy confers signicant physiologic advantages in most patients, particularly those with preoperative pulmonary impairment. There exists the possibility of interval aneurysm degeneration and rupture between two operations in the staged hybrid approach. Proponents of this technique thus advocate its use in patients considered high risk such as those with chronic obstructive pulmonary disease, coronary artery disease, or chronic renal insufciency [49]. These groups typically stage the open debranching operation 2–4months prior to the endovascular procedure, citing the avoidance of uid shifts and hemody­namic instability, which can result in a higher risk of paraple­gia if performed concomitantly with endografting [49].
Summary
The outcomes of open TAAA repair have greatly improved over the years and contemporary 30-day survival rates are quoted over 90%. The highest survival rate published to date was also the largest series ever reported, indicating
that high volume centers can achieve the best outcomes in this complex disease process. Whilst sounding less inva­sive, hybrid and endovascular approaches still carry the sig­nicant risk of morbidity and mortality compared with the open procedures. It is reasonable to assume that with increased use of endovascular techniques, an era will arrive in which TAAAs may be more universally treated with less invasive techniques. At present, open repair remains the best option for the majority of patients to achieve good long-term results.
References
1. Clouse WD, Hallett JW Jr, Schaff HV, Gayari MM, Ilstrup DM, Melton LJ 3rd. Improved prognosis of thoracic aortic aneurysms: a population-based study. JAMA. 1998;280(22):1926–9.
2. Etheredge SN, Yee J, Smith JV, Schonberger S, Goldman MJ. Successful resection of a large aneurysm of the upper abdominal aorta and replacement with homograft. Surgery. 1955;38(6):1071–81.
3. DeBakey ME, Crawford ES, Garrett HE, Beall AC Jr, Howell JF. Surgical considerations in the treatment of aneurysms of the thoraco-abdominal aorta. Ann Surg. 1965;162(4):650–62.
4. Crawford ES.Thoraco-abdominal and abdominal aortic aneurysms involving renal, superior mesenteric, celiac arteries. Ann Surg. 1974;179(5):763–72.
5. Santilli JD, Santilli SM.Diagnosis and treatment of abdominal aor­tic aneurysms. Am Fam Physician. 1997;56(4):1081–90.
6. Bickerstaff LK, Pairolero PC, Hollier LH, Melton LJ, et al. Thoracic aortic aneurysms: a population-based study. Surgery. 1982;92(6):1103–8.
7. Elefteriades JA. Natural history of thoracic aortic aneurysms: indications for surgery, and surgical versus nonsurgical risks. Ann Thorac Surg. 2002;74(5):S1877–80; discussion S1892–8.
8. Crawford ES, Crawford JL, Sa HJ, Coselli JS, et al. Thoracoabdominal aortic aneurysms: preoperative and intraopera­tive factors determining immediate and long-term results of opera­tions in 605 patients. J Vasc Surg. 1986;3(3):389–404.
9. Sa HJ, Miller CC 3rd. Spinal cord protection in descending thoracic and thoracoabdominal aortic repair. Ann Thorac Surg. 1999;67(6):1937–9; discussion 1953–8.
10. LaRoy LL, Cormier PJ, Matalon TA, Patel SK, Turner DA, Silver B.Imaging of abdominal aortic aneurysms. AJR Am J Roentgenol. 1989;152(4):785–92.
11. Olsson C, Thelin S, Ståhle E, Ekbom A, Granath F. Thoracic aortic aneurysm and dissection: increasing prevalence and improved outcomes reported in a nationwide population-based study of more than 14,000 cases from 1987 to 2002. Circulation. 2006;114(24):2611–8.
12. Ikonomidis JS, Barbour JR, Amani Z, Stroud RE, etal. Effects of deletion of the matrix metalloproteinase 9 gene on development of murine thoracic aortic aneurysms. Circulation. 2005;112(9 Suppl):I242–8.
13. Andreotti L, Bussotti A, Cammelli D, di Giovine F, etal. Aortic connective tissue in ageing–a biochemical study. Angiology. 1985;36(12):872–9.
14. Carlson RG, Lillehei CW, Edwards JE. Cystic medial necrosis of the ascending aorta in relation to age and hypertension. Am J Cardiol. 1970;25(4):411–5.
15. Ruddy JM, Jones JA, Ikonomidis JS.Pathophysiology of thoracic aortic aneurysm (TAA): is it not one uniform aorta? Rule of embry­ologic origin. Prog Cardiovasc Dis. 2013;56(1):68–73.
198
https://t.me/med1917
A. Venkataraman and J. P. Schwartz
16. Frederick JR, Woo YJ.Thoracoabdominal aortic aneurysm. Ann Cardiothorac Surg. 2012;1(3):277–85.
17. Panneton JM, Hollier LH.Nondissecting thoracoabdominal aortic aneurysms: part I.Ann Vasc Surg. 1995;9(5):503–14.
18. Ito S, Akutsu K, Tamori Y, Sakamoto S, Yoshimuta T, Hashimoto H, Takeshita S. Differences in atherosclerotic proles between patients with thoracic and abdominal aortic aneurysms. Am J Cardiol. 2008;101(5):696–9.
19. Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, etal. 2010 ACCF/ AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic dis­ease. A report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Catheter Cardiovasc Interv. 2010;76(2):E43–86.
20. Dapunt OE, Galla JD, Sadeghi AM, Lansman SL, etal. The natu­ral history of thoracic aortic aneurysms. J Thorac Cardiovasc Surg. 1994;107(5):1323–32; discussion 1332–3.
21. Elefteriades JA, Farkas EA. Thoracic aortic aneurysm clinically pertinent controversies and uncertainties. J Am Coll Cardiol. 2010;55(9):841–57.
22. Griepp RB, Ergin MA, Galla JD, Lansman SL, etal. Natural his­tory of descending thoracic and thoracoabdominal aneurysms. Ann Thorac Surg. 1999;67(6):1927–30; discussion 1953–8.
23. Davies RR, Gallo A, Coady MA, Tellides G, etal. Novel measure­ment of relative aortic size predicts rupture of thoracic aortic aneu­rysms. Ann Thorac Surg. 2006;81(1):169–77.
24. Elefteriades JA, Botta DM Jr. Indications for the treatment of tho­racic aortic aneurysms. Surg Clin North Am. 2009;89(4):845–67, ix.
25. Svensson LG, Crawford ES, Hess KR, Coselli JS, Sa HJ. Experience with 1509 patients undergoing thoracoabdomi­nal aortic operations. J Vasc Surg. 1993;17(2):357–68; discussion 368–70.
26. Svensson LG, Coselli JS, Sa HJ, Hess KR, Crawford ES.Appraisal of adjuncts to prevent acute renal failure after surgery on the tho­racic or thoracoabdominal aorta. J Vasc Surg. 1989;10(3):230–9.
27. Huynh TT, van Eps RG, Miller CC 3rd, Villa MA, etal. Glomerular ltration rate is superior to serum creatinine for prediction of mortality after thoracoabdominal aortic surgery. J Vasc Surg. 2005;42(2):206–12.
28. Kim SC, Singh M, Huang J, Prestigiacomo CJ, Winfree CJ, Solomon RA, Connolly ES Jr. Matrix metalloproteinase-9in cere­bral aneurysms. Neurosurgery. 1997;41(3):642–66; discussion 646–7.
29. Ziganshin BA, Elefteriades JA.Guilt by association: a paradigm for detection of silent aortic disease. Ann Cardiothorac Surg. 2016;5(3):174–87.
30. Hua HT, Cambria RP, Chuang SK, Stoner MC, et al. Early out­comes of endovascular versus open abdominal aortic aneurysm repair in the National Surgical Quality Improvement Program­Private Sector (NSQIP-PS). J Vasc Surg. 2005;41(3):382–9.
31. Zierer A, Melby SJ, Lubahn JG, Sicard GA, Damiano RJ Jr, Moon MR.Elective surgery for thoracic aortic aneurysms: late functional status and quality of life. Ann Thorac Surg. 2006;82(2):573–8.
32. Melissano G, Bertoglio L, Mascia D, Rinaldi E, etal. Spinal cord ischemia is multifactorial: what is the best protocol? J Cardiovasc Surg. 2016;57(2):191–201.
33. Sa HJ, Miller CC 3rd, Huynh TT, Estrera AL, etal. Distal aortic perfusion and cerebrospinal uid drainage for thoracoabdominal and descending thoracic aortic repair: ten years of organ protection. Ann Surg. 2003;238(3):372–80; discussion 380–1.
34. Aftab M, Coselli JS.Renal and visceral protection in thoracoabdom­inal aortic surgery. J Thorac Cardiovasc Surg. 2014;148(6):2963–6.
35. Coselli JS, LeMaire SA, Conklin LD, Köksoy C, Schmittling ZC.Morbidity and mortality after extent II thoracoabdominal aor­tic aneurysm repair. Ann Thorac Surg. 2002;73(4):1107–15; dis­cussion 1115–6.
36. Kulik A, Castner CF, Kouchoukos NT.Outcomes after thoracoab­dominal aortic aneurysm repair with hypothermic circulatory arrest. J Thorac Cardiovasc Surg. 2011;141(4):953–60.
37. Lemaire SA, Jones MM, Conklin LD, Carter SA, Criddell MD, Wang XL, Raskin SA, Coselli JS. Randomized comparison of cold blood and cold crystalloid renal perfusion for renal protec­tion during thoracoabdominal aortic aneurysm repair. J Vasc Surg. 2009;49(1):11–9; discussion 19.
38. Kuniyoshi Y, Koja K, Miyagi K, Uezu T, Yamashiro S, Arakaki K, Nagano T, Mabuni K, Senaha S.Selective visceral perfusion during thoracoabdominal aortic aneurysm repair. Ann Thorac Cardiovasc Surg. 2004;10(6):367–72.
39. Köksoy C, LeMaire SA, Curling PE, Raskin SA, Schmittling ZC, Conklin LD, Coselli JS. Renal perfusion during thoracoabdomi­nal aortic operations: cold crystalloid is superior to normothermic blood. Ann Thorac Surg. 2002;73(3):730–8.
40. Svensson LG, Crawford ES, Hess KR, Coselli JS, Sa HJ. Thoracoabdominal aortic aneurysms associated with celiac, superior mesenteric, and renal artery occlusive disease: methods and analysis of results in 271 patients. J Vasc Surg. 1992;16(3):378– 89; discussion 389–90.
41. LeMaire SA, Jamison AL, Carter SA, Wen S, Alankar S, Coselli JS. Deployment of balloon expandable stents during open repair of thoracoabdominal aortic aneurysms: a new strategy for manag­ing renal and mesenteric artery lesions. Eur J Cardiothorac Surg. 2004;26(3):599–607.
42. Browne TF, Hartley D, Purchas S, Rosenberg M, Van Schie G, Lawrence-Brown M.A fenestrated covered suprarenal aortic stent. Eur J Vasc Endovasc Surg. 1999;18(5):445–9.
43. Roselli EE, Greenberg RK, Pfaff K, Francis C, Svensson LG, Lytle BW. Endovascular treatment of thoracoabdominal aortic aneu­rysms. J Thorac Cardiovasc Surg. 2007;133(6):1474–82.
44. Greenberg RK, Lu Q, Roselli EE, Svensson LG, etal. Contemporary analysis of descending thoracic and thoracoabdominal aneu­rysm repair: a comparison of endovascular and open techniques. Circulation. 2008;118(8):808–17.
45. Eagleton MJ, Follansbee M, Wolski K, Mastracci T, Kuramochi Y. Fenestrated and branched endovascular aneurysm repair out­comes for type II and III thoracoabdominal aortic aneurysms. J Vasc Surg. 2016;63(4):930–42.
46. O’Callaghan A, Mastracci TM, Eagleton MJ. Staged endovascular repair of thoracoabdominal aortic aneurysms limits incidence and severity of spinal cord ischemia. J Vasc Surg. 2015;61(2):347–354.e1.
47. Mastracci TM, Greenberg RK, Eagleton MJ, Hernandez AV.Durability of branches in branched and fenestrated endografts. J Vasc Surg. 2013;57(4):926–33; discussion 933.
48. Yamaguchi D, Jordan WD Jr. Hybrid thoracoabdominal aor­tic aneurysm repair: current perspectives. Semin Vasc Surg. 2012;25(4):203–7.
49. Chao AB, Major K, Hood DB, Patel KR, Rowe VL, Weaver FA.Preliminary retrograde visceral artery reconstruction for thora­coabdominal aortic aneurysms. Ann Vasc Surg. 2007;21(2):123–8.
Abdominal Aortic Aneurysms
https://t.me/med1917
JoshuaD.Newman, AfaqMotiwala, AlexanderTurin, AndrewChen, ValmikiRishiMaharaj, andRobertS.Dieter
14
Abbreviations
18
F-FDG AAA Abdominal aortic aneurysm ACE Angiotensin-converting enzyme ADAM Aneurysm Detection and Management CAD Coronary artery disease CAESAR Comparison of surveillance versus aortic
CEUS Contrast-enhanced ultrasonography CI Condence interval COPD Chronic obstructive pulmonary disease CTA Computed tomographic angiography DREAM Dutch Randomized Endovascular Aneurysm
DUS Duplex ultrasound EVAR Endovascular aneurysm repair FAST Focused Assessment with Sonography in
HR Hazard ratio IAAA Inammatory abdominal aortic aneurysm MMP Matrix metalloproteinases MRA Magnetic resonance angiography MRI Magnetic resonance imaging
J. D. Newman (*) · A. Turin Cardiology, Loyola University Medical Center, Maywood, IL, USA
A. Motiwala Cardiovascular Diseases, Loyola University Medical Center, Maywood, IL, USA
A. Chen Cardiology, University of Nevada, School of Medicine, Las Vegas, NV, USA
V. R. Maharaj Internal Medicine, Loyola University Medical Center, Maywood, IL, USA
R. S. Dieter Interventional Cardiology, Vascular and Endovascular Medicine, Loyola University Medical Center, Maywood, IL, USA
18
F-uoro-deoxy-glucose
endografting for small aneurysm repair
Management
Trauma
OR Odds ratio OVER Open Versus Endovascular Repair PAD Peripheral artery disease PET Positron emission tomography PIVOTAL Positive Impact of Endovascular Options for
treating Aneurysms Early
SPECT Single-photon emission computer
tomography UKSAT UK Small Aneurysm Trial US Ultrasound USPSTF US Preventative Services Task Force
Introduction andDenitions
Aneurysm derives from the Greek word ανɛυρυσμα (aneu­rusma), meaning widening, and can be dened as a perma­nent and irreversible localized dilatation of a vessel. An abdominal aortic aneurysm (AAA) is a permanent, localized dilatation of the abdominal aorta that exceeds the normal diameter by 50%.
The abdominal aorta begins at the level of the diaphragm and extends to its bifurcation into the left and right common iliac arteries. Normal aortic diameter varies with age, gender, and body habitus, but the average diameter of the adult human infrarenal aorta is about 2.0cm and typically less than 3.0cm. Thus, for the majority of patients, an infrarenal aorta with a maximum diameter3.0cm is considered aneurysmal [1].
Anatomy oftheAbdominal Aorta
The abdominal aorta is a retroperitoneal structure that begins superiorly at the diaphragm and extends down to the level of the forth lumbar vertebra, where it bifurcates into the right and left common iliac arteries (Fig.14.1) [3]. The aorta lies slightly left of midline, with the inferior vena cava adjacent to it on the right. The branches of the aorta include (superior to inferior) the left and right inferior phrenic arteries, left and
© Springer Nature Switzerland AG 2019 R. S. Dieter et al. (eds.), Diseases of the Aorta, https://doi.org/10.1007/978-3-030-11322-3_14
199
200
ar
in
arteries
https://t.me/med1917
Fig. 14.1 Anatomy of the
abdominal aorta. (From Tainter [2]. Reprinted with permission from Elsevier)
J. D. Newman et al.
Diaphragm
Celiae artery
Left gastric
artery
Right renal
tery and vein
Superior
mesenteric
artery
Splenic artery
Common hepatic artery
Left renal artery and ve
Gonadal arteries
Inferior mesenteric artery
Common iliac arteries
lnternal iliac arteries
External iliac
right middle suprarenal arteries, the celiac axis, superior mesenteric artery, left and right renal arteries, left and right gonadal arteries, inferior mesenteric artery, left and right common iliac artery, middle sacral artery, and the paired lumbar arteries. The common iliac artery bifurcates into the external iliac and internal iliac arteries at the pelvic inlet.
Similar to other arteries, the aortic wall is divided into three layers (from external to lumen): the tunica externa (or tunica adventitia), tunica media, and tunica intima. The vas­cular supply to the tunica externa and tunica media is pro­vided by an extensive network of small blood vessels known as the vasa vasorum [3].
Fusiform aneurysm: The circumference of the artery is impacted by the aneurysm (most aneurysms are fusiform).
Saccular aneurysm: Only a part of the circumference of the artery is impacted by the aneurysm.
Inammatory aneurysm: Characterized by extensive peri­aneurysmal and retroperitoneal brosis and dense adhe­sions to adjacent abdominal organs [1].
Infectious (mycotic) aneurysm: Aneurysm caused by an infectious agent, most commonly bacterial (most com­monly Staphylococcus aureus, Salmonella, and Streptococcus pneumonia) [6].
Another commonly used classication modality is based
Classication
Aneurysms can be categorized by morphological character­istics, location, or etiology. The following are terms that dene aneurysms based on morphology (Fig.14.2) [5].
on location within the aorta (Fig.14.3) [8]:
Suprarenal aneurysm: Involves the origins of one or more visceral arteries but does not extend into the chest.
Pararenal aneurysm: The renal arteries arise from the aneurysmal aorta; however, the aorta at the level of the
True aneurysm: An aneurysm that involves all three layers of the arterial wall (intima, media, and adventitia).
False aneurysm (pseudoaneurysm): A collection of blood or hematoma that has leaked out of the artery but is then conned by the surrounding tissue.
superior mesenteric artery is not aneurysmal.
Juxtarenal aneurysm: Originates just beyond the origins of the renal arteries. There is no segment of nonaneurys­mal aorta distal to the renal arteries, but the aorta at the level of the renal arteries is not aneurysmal.
Tr ue aneurysm False (pseudo) aneurysm
Thoracoabdomina
14 Abdominal Aortic Aneurysms
https://t.me/med1917
Fig. 14.2 Aneurysm
morphologies. (From Netscher etal. [4]. Reprinted with permission from Elsevier)
201
Three normal vessel lamina
Fusiform aneurysm
Lack of three-layered structure of normal blood vessel
Sacular aneurysm
Infrarenal Juxtarenal Pararenal
Fig. 14.3 Abdominal aortic aneurysms described by their location in relation to the renal arteries. (From Goldstone [7]. Reprinted with permis-
sion from Elsevier)
Suprarenal
202
https://t.me/med1917
J. D. Newman et al.
Infrarenal aneurysm: Originates distal to the renal arter­ies. There is a segment of nonaneurysmal aorta that extends distal to the origins of the renal arteries.
Thoracoabdominal aneurysm: Originates in the chest and may involve the visceral or renal vessels.
Abdominal aortic aneurysms (AAA) most often affect the
segment of aorta between the renal and inferior mesenteric arteries [9].
Pathophysiology
The development of abdominal aortic aneurysms is associ­ated with alterations of the connective tissue in the aortic wall. Elastic bers and brillar collagen are the main deter­minants of the mechanical properties of the aorta. Elastin and associated proteins form a network of elastic bers responsible for the viscoelastic properties of the aorta. Elastin is stabilized by cross-links between the molecules and is degraded by specic proteases that display elastase activity. Elastic bers associated with smooth muscle cells are most abundant in the media of the aortic wall. Collagen, in polymeric form, is also a signicant component of the media and the surrounding brous adventitia.
One of the major histological features of aneurysmal tis-
sue is fragmentation of elastic bers and a decreased concen­tration of elastin. The loss of elastic bers seems to be an early step in aneurysm formation. Although elastin fragmen­tation and medial attenuation are the most important charac­teristics of the wall of an aneurysm, the adventitial tissue, in which collagen is predominant, is responsible for the resis­tance of the aorta in the absence of medial elastin. Therefore, while loss of elastin leads to aneurysm formation, collagen degradation is thought to be the ultimate cause of aneurysm rupture [5].
Collagen production continues throughout life and is even
increased in the aneurysmal wall. Besides enhanced collagen synthesis, however, collagenolytic activity is increased in AAA as well. This increased lytic activity is why several hereditary connective tissue disorders (e.g., Ehlers-Danlos and Marfan’s syndromes) are associated with aneurysm for­mation at an early age [8].
The alteration of elastin and collagen in the aortic wall is
dependent on production of proteases by nearby vascular wall cells (medial smooth muscle cells and adventitial bro­blasts) and by the cells of the lymphomonocytic inltrate. These inammatory cells in the media and adventitia come from the aortic blood and from a medial neovascularization, which characterizes abdominal aortic aneurysms. Leukocyte recruitment into the aortic wall is promoted by elastin degra­dation fragments as well as proinammatory cytokines, che­mokines, and prostaglandin derivatives produced by both the
resident mesenchymal cells and the inammatory cells themselves. Elastic and collagen bers are degraded by pro­teolytic enzymes mostly represented by matrix metallopro­teinases (MMP) locally activated by either other MMP or by plasmin generated by plasminogen activators.
Besides rarefaction of its extracellular matrix, the elastic media also undergo a reduction in the density of smooth mus­cle cells, which is regarded as a key event in the development of abdominal aortic aneurysms. Smooth muscle cells partici­pate in vascular wall remodeling through localized expression of various extracellular matrix proteins as well as proteases and their inhibitors. Additionally, smooth muscle cells have a protective role against inammation and proteolysis.
The development of abdominal aortic aneurysms is also associated with a mural thrombus in a number of patients. By contrast with arterial occlusive diseases, blood ow is maintained in aortic aneurysms resulting in a persistent remodeling activity of the components of the thrombus. Although the thrombus can substantially reduce aneurysmal wall stress, its increasing thickness leads to local hypoxia at the inner layer of the media, which can induce increased medial neovascularization and inammation. This appears to play a role in aneurysmal degeneration associated with an adherent thrombus [1]. Some data suggests that thrombus may actually increase risk of aneurysm rupture, presumably due to localized tissue hypoxia and diminished wall strength [1013].
Risk Factors
The common risk factors of AAA are smoking, male gender, white race, older age, chronic obstructive pulmonary disease (COPD), hypertension, dyslipidemia, coronary artery disease (CAD), peripheral artery disease (PAD), and positive family history [14]. Interestingly, although diabetes mellitus is a risk factor for PAD and CAD, it has been found to be a negative risk factor for AAA development and growth [15, 16].
Age
Elastin is not synthesized in the adult aorta. With a half-life of 70years, the amount of elastin in the aortic wall decreases with age. The age-related alterations in the vessel wall affect the mechanical properties of the aorta. This explains why AAA is primarily a disease of the elderly [8].
Atherosclerosis
The historical association of AAA with atherosclerosis has now expanded into a multifactorial causation for the disease.
14 Abdominal Aortic Aneurysms
https://t.me/med1917
203
It is unclear why atherosclerosis, normally causing narrow­ing of the arterial lumen, should in some cases result in dilation. There are epidemiological differences between patients with obstructive vascular and aneurysmal disease. Histological examination of the aneurysm wall reveals a chronic adventitial and medial inammatory inltrate of varying intensity. This distinguishes AAA from the purely atherosclerotic aorta, in which inammatory cells are mainly associated with plaque. Patients with obstructive peripheral vascular disease also carry an increased risk for AAA.It is also important to remember that both AAA and peripheral arterial disease share many common risk factors (such as age, gender, smoking, hypertension, and hyperlipidemia, among others) [8].
Smoking
Smoking is the risk factor most strongly associated with AAA.Men who currently smoke more than 25 cigarettes per day have a 15-fold increased risk of AAA (hazard ratio [HR]
14.6, 95% CI 9.6–22) compared with men who have never smoked [17]. A smoker’s risk of developing AAA continues for at least 10years following smoking cessation. In spite of this association, however, no causative link has been proven between smoking and AAA formation. The mechanism by which cigarette smoking contributes to aneurysm formation is independent of atherosclerosis. Theories behind the patho­physiology include disruption in collagen synthesis, altered expression of metalloproteinases, and the response to oxida­tive stress [18].
Patients with smoking history are more likely to develop COPD.As is the case in AAA, COPD is driven by excess matrix turnover and proteolysis. A large meta-analysis recently showed a 1.8-fold increase prevalence and incidence of AAA in patients with COPD compared to those without it [19]. Further, some studies suggest that COPD increases the risk of AAA rupture [20].
involved in pathogenesis [ rupture risk in patients with established AAAs [14].
5]. Hypertension also increases
Hyperlipidemia
High-serum total cholesterol has a positive association with AAA prevalence, whereas high-density lipoprotein choles­terol has an inverse association. This correlation may be related to the increased risk of atherosclerosis, or may in part be a direct factor [21]. Similarly, obesity has also been shown to be an independent risk factor [18].
Family History/Genetic Factors
Positive family history has been shown to be a major risk factor for development of abdominal aortic aneurysm. A study by Larsson and colleagues showed the overall relative risk of AAA associated with family history compared to no family history was 1.9 (95% condence interval [CI] 1.6–
2.2) [22]. The development of AAAs is unlikely to be related to a
single gene mutation, and multiple genetic factors are impli­cated. Susceptibility genes, rather than causal gene muta­tions, are likely to be important, particularly those regulating inammatory mediators, tissue proteases, and smooth mus­cle cell biology [18].
Alcohol Intake
High levels of alcohol intake (>30g/day) have been associ­ated with increased risk of AAA (OR 1.65, 95% CI 1.03–
2.64) [17]. The mechanism through which alcohol exposure
increases the risk of AAA is unclear, but could be through upregulation of matrix metalloproteinases and focal elastin degradation.
Gender
Men are at much higher risk of AAA than women. The rea­sons for this are unclear, but it is likely to be a function of hormonal factors, genetic susceptibility, and risk factor exposure [18].
Hypertension
Hypertension enhances the growth rate of aneurysms and is associated with an increased prevalence of AAA, which indi­cates that an increased load on the aortic wall may be
Primary Disorders oftheAorta
A fraction of the cases of AAA are the direct consequence of disorders of the aorta itself or disruptions in the integrity of the aorta. Some of these causes include trauma, acute infec­tion (bacterial or fungal), chronic infection (tuberculosis), inammatory diseases (Behçet and Takayasu disease), and connective tissue disorders (Marfan’s syndrome, Ehlers­Danlos type IV) [1].
In spite of the nomenclature, mycotic aneurysms are
most often caused by bacterial pathogens, with fungi rarely being associated. The most commonly implicated organ­isms include Staphylococcus aureus, Salmonella, and